House and providers spar over 340B changes as Senate subcommittee hears SB 278 SB 278 would adjust 340B program enforcement and penalties in Virginia; hospitals and community clinics clashed over transparency, contract-pharmacy limits and whether the bill protects patient access or industry profits.

Virginia's Senate subcommittee is at the center of a heated debate over SB 278, as hospitals and community clinics clash over patient access versus industry profits in the 340B program.

Click to read more!

#VA #PharmaceuticalAccountability #TransparencyReform #PatientAccess #VirginiaHealthcare

Kansas Legislators Review 340B Drug Pricing Program Amid Concerns Over Pharmacy Restrictions Kansas safety net providers advocate for 340B program protections amid rising pharmaceutical costs.

Kansas legislators are raising alarms about the 340B drug pricing program, questioning its effectiveness and the growing influence of out-of-state pharmacies on local healthcare.

Get the details!

#KS #CitizenPortal #HealthcareAccess #PharmaceuticalAccountability #KansasHospitals #LocalEconomy

Cheshire Town Council authorizes participation in insulin pricing litigation Council approves resolution for no-cost legal counsel to investigate insulin price overcharging

Cheshire, Connecticut is taking a bold stand against skyrocketing insulin prices by joining a multi-district lawsuit to seek justice and reimbursement for overcharges!

Learn more here

#CT #CitizenPortal #PharmaceuticalAccountability #HealthcareCosts

Texas legislators pursue bill targeting deceptive vaccine advertising in defiance of federal law Texas lawmakers aim to challenge federal preemption by addressing deceptive vaccine advertising.

Texas lawmakers are taking a bold stand against deceptive vaccine advertising, challenging federal protections to hold manufacturers accountable for misleading claims.

Learn more here!

#TX #CitizenPortal #DeceptiveAdvertising #PharmaceuticalAccountability #VaccineSafetyClaims

Green Mountain Care Board mandates new reporting for hospitals in 340B drug program Hospitals must report drug costs and vendor participation to Green Mountain Care Board annually.

Vermont lawmakers are tackling the rising healthcare costs by pushing for greater transparency in drug pricing and hospital participation in the 340B program.

Get the details!

#VT #VermontHealthcare #HealthcareTransparency #CitizenPortal #PharmaceuticalAccountability #CostContainment

Senate approves Drug Competition Enforcement Act to curb pharmaceutical patent abuses Senators support legislation aimed at reducing drug prices by limiting patent system abuses.

The Senate has taken a monumental step to tackle soaring drug prices by passing the Drug Competition Enforcement Act, aiming to curb the manipulative tactics of pharmaceutical companies.

Learn more here

#US #CitizenPortal #ConnecticutSenate #HealthcareReform #PharmaceuticalAccountability

HCA cautiously supports Vermont's contract pharmacy protections amid litigation concerns HCA endorses contract pharmacy language in Vermont bill while highlighting litigation complexities.

The Vermont Senate is at a crossroads as healthcare advocates support critical contract pharmacy protections, but legal battles loom on the horizon.

Learn more here

#VT #LegalTransparency #CitizenPortal #HealthcareReform #VermontHealthcare #PharmaceuticalAccountability

A large building made of money and pill bottles with the name 'Sackler family' and a banner saying 'Settlement Reached' in a brutalist style.

A monumental structure symbolizes the costly settlement of the opioid crisis, with the Sackler family's name etched in a brutalist testament to accountability #OpioidCrisis #SacklerFamily #PharmaceuticalAccountability #SettlementReached #BrutalistArt

North Dakota health center leaders advocate for 340B program amid pharmaceutical policy changes Healthcare leaders emphasize 340B program's crucial role in providing affordable medications in rural areas.

Healthcare leaders in North Dakota are rallying to protect the 340B drug pricing program, which is essential for keeping medications affordable in rural communities.

Learn more here!

#ND #AffordableMedications #NorthDakotaHealthcare #CitizenPortal #RuralHealthcare #PharmaceuticalAccountability

North Dakota panel scrutinizes insulin market monopoly and pricing practices Discussion highlights insulin pricing issues and diabetes statistics in North Dakota.

Lawmakers in North Dakota are raising alarms over insulin pricing monopolies that leave patients struggling to afford life-saving medication.

Click to read more!

#ND #HealthcareAccess #InsulinAffordability #CitizenPortal #NorthDakotaDiabetes #PharmaceuticalAccountability

Oklahoma asserts authority to regulate pharmaceutical accountability and protect citizens Oklahoma safeguards its citizens' rights against federal overreach in pharmaceutical liability cases.

Oklahoma's bold Senate Bill 801 could revolutionize how pharmaceutical companies are held accountable for harm, sparking intense debate over public health versus innovation.

Click to read more!

#OK #CitizenPortal #PharmaceuticalAccountability #PublicHealthSafety #HealthcareLiability